{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:31:26Z","timestamp":1774686686960,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1016\/s0002-9149(98)00033-2","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:02:49Z","timestamp":1027645369000},"page":"18B-25B","source":"Crossref","is-referenced-by-count":381,"special_numbering":"S1","title":["Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome"],"prefix":"10.1016","volume":"81","author":[{"suffix":"MD, PhD","given":"Scott M","family":"Grundy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9149(98)00033-2_BIB1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.11.1.2","article-title":"Plasma triglyceride and coronary artery disease","volume":"11","author":"Austin","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein level","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.95.1.1","article-title":"Small LDL, atherogenic dyslipidemia, and the metabolic syndrome","volume":"95","author":"Grundy","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB6","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB7","first-page":"1329","article-title":"National Cholesterol Education Program","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB8","first-page":"1","article-title":"Atherosclerosis in primates","volume":"9","author":"Strong","year":"1976","journal-title":"Primates Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB9","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1981","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"1995"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB10","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary artery disease and lipoprotein cholesterol levels","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB11","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary artery disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary artery disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB13","doi-asserted-by":"crossref","unstructured":"Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole triglyceride, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001\u20131009.","DOI":"10.1056\/NEJM199610033351401"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB14","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1953","article-title":"Type III hypolipoproteinemia (dysbetalipoproteinemia)","author":"Mahley","year":"1995"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0025-7125(16)31426-2","article-title":"Atherogenic hyperlipoproteinemia","volume":"66","author":"Mahley","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0005-2760(89)90346-9","article-title":"Impaired triacylglycerol catabolism in hypertriglyceridemia of the diabetic, cholesterol-fed rabbit","volume":"1002","author":"Minnich","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB18","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1913","article-title":"Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome","author":"Brunzell","year":"1995"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0026-0495(76)90089-5","article-title":"Myocardial infarction in familial forms of hypertriglyceridemia","volume":"25","author":"Brunzell","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-2275(20)38008-1","article-title":"Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia","volume":"24","author":"Brunzell","year":"1983","journal-title":"J Lipid Res"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","article-title":"Epidemiology as a guide to clinical decisions","volume":"302","author":"Hulley","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/hrt.40.10.1069","article-title":"A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate","volume":"40","year":"1978","journal-title":"Br Heart J"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(96)91343-4","article-title":"Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients","volume":"347","author":"Ericcson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(87)90866-7","article-title":"Fibric acids","volume":"83","author":"Grundy","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in coronary drug project patients","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0954-6820.1988.tb15891.x","article-title":"Reduction of mortality in the Stockholm ischaemic heart disease secondary prevention study to combined treatment with clofibrate and nicotinic acid","volume":"223","author":"Carlson","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.ATV.10.5.668","article-title":"Does measurement of apolipoprotein B have a place in cholesterol management?","volume":"10","author":"Vega","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(93)90187-Y","article-title":"Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100","volume":"104","author":"Abate","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-97-6-833","article-title":"Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis","volume":"97","author":"Sniderman","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.ATV.1.4.273","article-title":"Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction","volume":"1","author":"Fager","year":"1981","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB33","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.CIR.94.10.2381","article-title":"Serum lipids and incidence of coronary artery disease","volume":"94","author":"Frost","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.1990.00390180119022","article-title":"Management of primary mixed hyperlipidemia with lovastatin","volume":"150","author":"Vega","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM198801143180204","article-title":"Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus","volume":"318","author":"Garg","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB36","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0002-9149(97)00109-4","article-title":"Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia","volume":"79","author":"Mostaza","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/diacare.13.2.153","article-title":"Management of dyslipidemia in NIDDM","volume":"13","author":"Garg","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB38","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0002-9149(89)90181-1","article-title":"Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease","volume":"63","author":"Richards","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(78)91863-9","article-title":"Plasma triglycerides in regulation of HDL-cholesterol","volume":"2","author":"Schaefer","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.ATV.13.8.1227","article-title":"Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol","volume":"13","author":"Blades","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.13.2.147","article-title":"Effect of hepatic lipase on LDL in normal men and those with coronary artery disease","volume":"13","author":"Zambon","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-2275(20)38270-5","article-title":"Post-heparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyper-alphalipoproteinemia","volume":"30","author":"Kuusi","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.ATV.13.4.579","article-title":"Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia","volume":"13","author":"Vega","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archinte.1992.00400130054004","article-title":"Two different views of the relationship of hypertriglyceridemia to coronary artery disease","volume":"152","author":"Grundy","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00041433-199412000-00002","article-title":"Characterization of low-density lipoprotein subclasses","volume":"5","author":"Austin","year":"1994","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low density lipoprotein phenotype as a predictor of the risk of ischemic heart disease in men","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.ATV.11.2.298","article-title":"Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfractions in healthy subjects","volume":"11","author":"de Graaf","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma high density lipoprotein concentration and development of ischaemic heart disease","volume":"i","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary artery disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB50","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2031","article-title":"Familial disorders of high density lipoproteins","author":"Breslow","year":"1989"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB51","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","article-title":"Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in apolipoprotein E-deficient mouse","volume":"91","author":"Plump","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB52","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1001\/jama.1985.03350400082026","article-title":"Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary artery disease","volume":"253","author":"Vega","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-109-1-25","article-title":"Combination drug therapy for familial combined hyperlipidemia","volume":"109","author":"East","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB54","series-title":"Diabetes Mellitus","first-page":"509","article-title":"Insulin resistance and its consequences","author":"Reaven","year":"1996"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB55","doi-asserted-by":"crossref","unstructured":"Mostaza JM, Vega GL, Snell P, Grundy SM. Abnormal metabolism of free fatty acids in hypertriglyceridemic man: apparent insulin resistance of adipose tissue. J Intern Med 1997 (in press).","DOI":"10.1046\/j.1365-2796.1998.00298.x"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF01220632","article-title":"Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridemia in man","volume":"12","author":"Kissebah","year":"1976","journal-title":"Diabetalogia"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0026-0495(94)90222-4","article-title":"Associations between insulin sensitivity and free fatty acid and triglyceride metabolism independent of uncomplicated obesity","volume":"43","author":"Bruce","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0026-0495(75)90145-6","article-title":"Hepatic steatosis and the elevated plasma insulin level in patients with endogenous hypertriglyceridemia","volume":"24","author":"Maruhama","year":"1975","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB59","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1007\/BF00400839","article-title":"Mechanisms modifying glucose oxidation in diabetes mellitus","volume":"37","author":"Randle","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB60","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats","volume":"91","author":"Lee","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.ATV.12.6.647","article-title":"Atherogenesis in diabetes","volume":"12","author":"Bierman","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB62","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","article-title":"Hypertension and associated metabolic abnormalities\u2014the role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0026-0495(90)90071-J","article-title":"Insulin resistance is a characteristic feature of primary hypertension independent of obesity","volume":"39","author":"Pollare","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00403280","article-title":"Increased plasma plasminogen activator inhibitor 1 levels","volume":"34","author":"Juhan-Vague","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9149(98)00033-2_BIB65","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.ATV.13.12.1865","article-title":"Involvement of the hemostatic system in the insulin resistance syndrome. (Abstr.)","volume":"13","author":"Juhan-Vague","year":"1993","journal-title":"Arterioscler Thromb"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914998000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914998000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:33:36Z","timestamp":1620938016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914998000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0002914998000332"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(98)00033-2","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}